Skip to main content
. 2021 May 5;13(3):245–253. doi: 10.5114/jcb.2021.105846

Table 2.

Freedom from prostate specific antigen (PSA) failure at 5 and 7 years from Kaplan-Meier calculation

Risk group All 4F All 3F All 2F LR 3F LR 2F IR 3F IR 2F
5-year 89% 96% 90% 99% 98% 86% 72%
7-year 89% 96% 85% 99% 92% 86% 72%

LR – low-risk, IR – intermediate-risk